Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells
about
Role of lectin-like oxidized low density lipoprotein-1 in fetoplacental vascular dysfunction in preeclampsiaLOX-1 in atherosclerosis: biological functions and pharmacological modifiers.Aspirin resistance: Fact or fiction? A point of view.Endothelial arginase II and atherosclerosis.The discovery of LOX-1, its ligands and clinical significance.Structure-based Design Targeted at LOX-1, a Receptor for Oxidized Low-Density Lipoprotein.Acetylsalicylic acid, but not clopidogrel, inhibits therapeutically induced cerebral arteriogenesis in the hypoperfused rat brainCryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E-deficient mice: role of lectin-like oxidized LDL receptor-1 (LOX-1).MiR-590-5p Inhibits Oxidized- LDL Induced Angiogenesis by Targeting LOX-1An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration.Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?Matrix metalloproteinases: drug targets for myocardial infarction.Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1.Chewing the fat: genetic approaches to model dyslipidemia-induced diabetic neuropathy in miceAbsence of clinical relationship between oxidized low density lipoproteins and diabetic peripheral neuropathy: a case control study.Evaluation of 12-lipoxygenase (12-LOX) and plasminogen activator inhibitor 1 (PAI-1) as prognostic markers in prostate cancer.LOX-1/LOXIN: the yin/yang of atheroscleorosis.LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complications.Lectin-like oxidized low-density lipoprotein receptor 1 pathways.The lectin-like oxidized low-density lipoprotein receptor-1 as therapeutic target for atherosclerosis, inflammatory conditions and longevity.LOX-1, a new marker of risk and prognosis in coronary artery disease?LOX-1 and ROS, inseparable factors in the process of endothelial damage.Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.Acetylsalicylic acid inhibits IL-18-induced cardiac fibroblast migration through the induction of RECKEffects of preoperative aspirin on perioperative platelet activation and dysfunction in patients undergoing off-pump coronary artery bypass graft surgery: A prospective randomized study.EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling.Oxidative Stress in Atherosclerosis.Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone.Nobiletin, a citrus flavonoid, suppresses phorbol ester-induced expression of multiple scavenger receptor genes in THP-1 human monocytic cells.Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: a novel cytoprotective role of aspirin in acute myocardial infarction.Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells: role of reactive oxygen species.
P2860
Q33944749-852F5DA0-493A-4FAE-967E-FB60E7C44C5AQ34079451-5D12C766-299E-4688-994E-972DE51B4FD7Q34389630-06F233E6-C1AF-47A4-A9FD-00381EE4F3BAQ35161493-D522127E-A656-42EF-8938-9EE8A135701FQ35475499-2A923BDC-57F6-4819-84E7-2A08E289FB57Q35844550-B9BC0FBC-80B1-4984-ABAA-C94CE9EEDE64Q35880859-215FE2FB-366E-45F1-A562-E38439F1C587Q36342164-247A40AD-C34E-4F52-9C25-91285BF5E05AQ36638558-C396071A-F04D-4EA7-A637-A3B5174055E9Q36851683-B7CC37A0-5CFE-489C-9FDA-C58CB8F87DFFQ36872076-1068772B-8808-4810-8768-81387471D9F2Q37308645-4A03471D-F012-4491-ACFB-66B7AFF7E1C8Q37360464-3F64780F-23F4-4D19-A4E0-8E0B195FC271Q37572538-658187E2-DECE-4850-8D4C-B2830245D765Q37600743-8E1AF735-6399-4C43-A351-7A617673CAA3Q37695659-1B13FEBD-624B-4FE4-80A1-027952B4402EQ37929625-E1F8CB87-9824-4BDB-B44F-2E780135FFDBQ37945097-06517980-88D2-4A29-A898-C247D327FFDCQ38099693-5679B219-1105-4A8C-837A-C863CF9F2D85Q38112162-80BE4229-A060-4212-84D7-490BA009646DQ38128195-4F106332-5E40-458F-A2B3-3CCE8BBF017FQ38216728-DF017E75-552B-4BBF-9198-14565EB4FFE7Q38299279-65BF881B-68FA-4940-822B-8DA81397E457Q38729906-D6CF9C2C-A231-413F-A883-1D677B48FD44Q39058582-C66938DD-7D72-4B3C-AA1C-D2F3247763E5Q41034693-B5DF84CF-AE91-4772-8B8C-652EEFF98F9CQ43142712-93BEA972-D7F0-4C25-B5DF-A4241E40F9F8Q46305239-A2FFDD42-3840-439C-BD9E-1CC66878107DQ53621856-C238E25B-1C26-4F96-AAE2-137CED03BFC2Q53623040-AFB1362A-FD83-4278-BE96-565412A601D9Q54442432-32138A95-3C7B-4DB5-8024-91BCEA598253Q54632828-374AAAEB-06FA-4768-AE1B-271305A6DEC7
P2860
Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Aspirin inhibits ox-LDL-mediat ...... man coronary endothelial cells
@ast
Aspirin inhibits ox-LDL-mediat ...... man coronary endothelial cells
@en
Aspirin inhibits ox-LDL-mediat ...... man coronary endothelial cells
@nl
type
label
Aspirin inhibits ox-LDL-mediat ...... man coronary endothelial cells
@ast
Aspirin inhibits ox-LDL-mediat ...... man coronary endothelial cells
@en
Aspirin inhibits ox-LDL-mediat ...... man coronary endothelial cells
@nl
prefLabel
Aspirin inhibits ox-LDL-mediat ...... man coronary endothelial cells
@ast
Aspirin inhibits ox-LDL-mediat ...... man coronary endothelial cells
@en
Aspirin inhibits ox-LDL-mediat ...... man coronary endothelial cells
@nl
P2093
P1476
Aspirin inhibits ox-LDL-mediat ...... man coronary endothelial cells
@en
P2093
P356
10.1016/J.CARDIORES.2004.07.002
P407
P577
2004-11-01T00:00:00Z